Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Kidney disease drug trial halted before it began

NCT ID NCT06120673

First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 16 times

Summary

This study aimed to compare a newer drug, obinutuzumab, with a standard treatment (steroids and cyclophosphamide) for people with primary membranous nephropathy, a kidney condition. The goal was to see which approach worked better at controlling the disease, caused fewer side effects, and improved quality of life. However, the trial was withdrawn before enrolling any participants.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY MEMBRANOUS NEPHROPATHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Bundaberg Hospital

    Bundaberg, Queensland, Australia

  • Cairns Hospital

    Cairns, Queensland, Australia

  • Canberra Hospital

    Garran, Australian Capital Territory, Australia

  • Fiona Stanley Hospital

    Murdoch, Western Australia, Australia

  • Logan Hospital

    Logan City, Queensland, Australia

  • Mackay Base Hospital

    Mackay, Queensland, Australia

  • Mater Hospital

    South Brisbane, Queensland, Australia

  • Princess Alexandra Hospital

    Woolloongabba, Queensland, Australia

  • Rockhampton Hospital

    Rockhampton, Queensland, Australia

  • Royal Brisbane and Women's Hospital

    Brisbane, Queensland, Australia

  • Royal Hobart Hospital

    Hobart, Tasmania, Australia

  • Royal Prince Alfred Hospital

    Camperdown, New South Wales, Australia

  • Sunshine Coast University Hospital

    Birtinya, Queensland, Australia

Conditions

Explore the condition pages connected to this study.